Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current HIV Research
  4. Fast Track Articles
  5. Fast Track Article
image of MicroRNA Expression in Exosome Extracellular Vesicles as Targets for Personalized Medicine in Diffuse Large B Cell Lymphoma Patients with HIV Infection

Abstract

Extracellular Vesicles (EVs), more specifically exosomes (xEVs), have been associated with Diffuse Large B-cell Lymphoma (DLBCL). These xEVs contain a variety of biomolecules, such as proteins and nucleic acids (, microRNA, LncRNA, and DNA). The expressions of these vesicles in the setting of Human Immunodeficiency Virus (HIV) have been linked to disease progression. Studies have explored the use of EVs in more practical clinical settings. Several studies have found that biomolecules within xEVs can serve to detect disease progression. The biomolecule content within xEVs is useful in prognostication and has even been associated with mechanisms of resistance for some DLBCL treatment modalities. This review article explores the role of xEV biomolecule content in DLBCL progression in the context of HIV infection and its applied use in practical disease management.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/chr/10.2174/011570162X288575240821201433
2024-10-04
2024-11-22

  • From This Site

    /content/journals/chr/10.2174/011570162X288575240821201433
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Laurini J.A. Perry A.M. Boilesen E. Diebold J. MacLennan K.A. Müller-Hermelink H.K. Nathwani B.N. Armitage J.O. Weisenburger D.D. Classification of non-Hodgkin lymphoma in Central and South America: A review of 1028 cases. Blood 2012 120 24 4795 4801 10.1182/blood‑2012‑07‑440073 23086753
    [Google Scholar]
  2. Ofori K. Bhagat G. Rai A.J. Exosomes and extracellular vesicles as liquid biopsy biomarkers in diffuse large B-cell lymphoma: Current state of the art and unmet clinical needs. Br. J. Clin. Pharmacol. 2021 87 2 284 294 10.1111/bcp.14611 33080045
    [Google Scholar]
  3. Sirsath N. Sathyanarayanan V. Setty G.B.K. Channaviriappa L.K. Nagendrappa L.K. Dasappa L. Human Immunodeficiency Virus - associated lymphomas: A neglected domain. N. Am. J. Med. Sci. 2013 5 7 432 437 10.4103/1947‑2714.115772 24020054
    [Google Scholar]
  4. Carbone A. Vaccher E. Gloghini A. Pantanowitz L. Abayomi A. de Paoli P. Franceschi S. Diagnosis and management of lymphomas and other cancers in HIV-infected patients. Nat. Rev. Clin. Oncol. 2014 11 4 223 238 10.1038/nrclinonc.2014.31 24614140
    [Google Scholar]
  5. Magangane P. Sookhayi R. Govender D. Naidoo R. Determining protein biomarkers for DLBCL using FFPE tissues from HIV negative and HIV positive patients. J. Mol. Histol. 2016 47 6 565 577 10.1007/s10735‑016‑9695‑y 27696080
    [Google Scholar]
  6. Li S. Young K.H. Medeiros L.J. Diffuse large B-cell lymphoma. Pathology 2018 50 1 74 87 10.1016/j.pathol.2017.09.006 29167021
    [Google Scholar]
  7. Xue Y. Wang Q. He X. Clear cell variant of diffuse large B-cell lymphoma: A case report and review of the literature. Int. J. Clin. Exp. Pathol. 2015 8 6 7594 7599 26261675
    [Google Scholar]
  8. Anyanwu S.I. Doherty A. Powell M.D. Obialo C. Huang M.B. Quarshie A. Mitchell C. Bashir K. Newman G.W. Detection of HIV-1 and human proteins in urinary extracellular vesicles from HIV+ patients. Adv. Virol. 2018 2018 1 16 10.1155/2018/7863412 29721020
    [Google Scholar]
  9. Dias M.V.S. Costa C.S. daSilva L.L.P. The ambiguous roles of extracellular vesicles in HIV replication and pathogenesis. Front. Microbiol. 2018 9 2411 10.3389/fmicb.2018.02411 30364166
    [Google Scholar]
  10. Thery C. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Current Protocol In Cell Biology Hoboken, New Jersey Wiley 2006 10.1002/0471143030.cb0322s30
    [Google Scholar]
  11. Colombo M. Moita C. van Niel G. Kowal J. Vigneron J. Benaroch P. Manel N. Moita L.F. Théry C. Raposo G. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J. Cell Sci. 2013 126 Pt 24 jcs.128868 10.1242/jcs.128868 24105262
    [Google Scholar]
  12. Zhang B. Wu X. Zhang X. Sun Y. Yan Y. Shi H. Zhu Y. Wu L. Pan Z. Zhu W. Qian H. Xu W. Human umbilical cord mesenchymal stem cell exosomes enhance angiogenesis through the Wnt4/β-catenin pathway. Stem Cells Transl. Med. 2015 4 5 513 522 10.5966/sctm.2014‑0267 25824139
    [Google Scholar]
  13. Zhang B. Wang M. Gong A. Zhang X. Wu X. Zhu Y. Shi H. Wu L. Zhu W. Qian H. Xu W. HucMSC-exosome mediated-wnt4 signaling is required for cutaneous wound healing. Stem Cells 2015 33 7 2158 2168 10.1002/stem.1771 24964196
    [Google Scholar]
  14. Akers J.C. Ramakrishnan V. Kim R. Skog J. Nakano I. Pingle S. Kalinina J. Hua W. Kesari S. Mao Y. Breakefield X.O. Hochberg F.H. Van Meir E.G. Carter B.S. Chen C.C. MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): A platform for glioblastoma biomarker development. PLoS One 2013 8 10 e78115 10.1371/journal.pone.0078115 24205116
    [Google Scholar]
  15. van Niel G. Théry C. Extracellular vesicles: Eat glutamine and spit acidic bubbles. EMBO J. 2020 39 16 e105119 10.15252/embj.2020105119 32809264
    [Google Scholar]
  16. Zhang Y. Liu Y. Liu H. Tang W.H. Exosomes: Biogenesis, biologic function and clinical potential. Cell Biosci. 2019 9 1 19 10.1186/s13578‑019‑0282‑2 30815248
    [Google Scholar]
  17. Kowal J. Tkach M. Théry C. Biogenesis and secretion of exosomes. Curr. Opin. Cell Biol. 2014 29 116 125 10.1016/j.ceb.2014.05.004 24959705
    [Google Scholar]
  18. Feng Y. Zhong M. Zeng S. Wang L. Liu P. Xiao X. Liu Y. Exosome-derived miRNAs as predictive biomarkers for diffuse large B-cell lymphoma chemotherapy resistance. Epigenomics 2019 11 1 35 51 10.2217/epi‑2018‑0123 30211623
    [Google Scholar]
  19. Roehle A. Hoefig K.P. Repsilber D. Thorns C. Ziepert M. Wesche K.O. Thiere M. Loeffler M. Klapper W. Pfreundschuh M. Matolcsy A. Bernd H.W. Reiniger L. Merz H. Feller A.C. MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas. Br. J. Haematol. 2008 142 5 732 744 10.1111/j.1365‑2141.2008.07237.x 18537969
    [Google Scholar]
  20. Lawrie C.H. Gal S. Dunlop H.M. Pushkaran B. Liggins A.P. Pulford K. Banham A.H. Pezzella F. Boultwood J. Wainscoat J.S. Hatton C.S.R. Harris A.L. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol. 2008 141 5 672 675 10.1111/j.1365‑2141.2008.07077.x 18318758
    [Google Scholar]
  21. Ji M. Rao E. Ramachandrareddy H. Shen Y. Jiang C. Chen J. Hu Y. Rizzino A. Chan W.C. Fu K. McKeithan T.W. The miR-17-92 microRNA cluster is regulated by multiple mechanisms in B-cell malignancies. Am. J. Pathol. 2011 179 4 1645 1656 10.1016/j.ajpath.2011.06.008 21806958
    [Google Scholar]
  22. Carvalho A.S. Baeta H. Henriques A.F.A. Ejtehadifar M. Tranfield E.M. Sousa A.L. Farinho A. Silva B.C. Cabeçadas J. Gameiro P. Silva M.G. Beck H.C. Matthiesen R. Proteomic landscape of extracellular vesicles for diffuse large B-cell lymphoma subtyping. Int. J. Mol. Sci. 2021 22 20 11004 10.3390/ijms222011004 34681663
    [Google Scholar]
  23. Di C. Jiang Y. Li M. Juan X. Xu C. Circulating exosomal microrna signature as a noninvasive biomarker for diagnosis of diffuse large B-cell lymphoma. Blood 2018 132 Suppl. 1 5406 5406 10.1182/blood‑2018‑99‑115940
    [Google Scholar]
  24. van Eijndhoven M.A.J. Zijlstra J.M. Groenewegen N.J. Drees E.E.E. van Niele S. Baglio S.R. Koppers-Lalic D. van der Voorn H. Libregts S.F.W.M. Wauben M.H.M. de Menezes R.X. van Weering J.R.T. Nieuwland R. Visser L. van den Berg A. de Jong D. Pegtel D.M. Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients. JCI Insight 2016 1 19 e89631 10.1172/jci.insight.89631 27882350
    [Google Scholar]
  25. Aharon A. Rebibo-Sabbah A. Tzoran I. Levin C. Extracellular vesicles in hematological disorders. Rambam Maimonides Med. J. 2014 5 4 e0032 10.5041/RMMJ.10166 25386348
    [Google Scholar]
  26. Diehl P. Fricke A. Sander L. Stamm J. Bassler N. Htun N. Ziemann M. Helbing T. El-Osta A. Jowett J.B.M. Peter K. Microparticles: Major transport vehicles for distinct microRNAs in circulation. Cardiovasc. Res. 2012 93 4 633 644 10.1093/cvr/cvs007 22258631
    [Google Scholar]
  27. Rutherford S.C. Fachel A.A. Li S. Sawh S. Muley A. Ishii J. Saxena A. Dominguez P.M. Caldas Lopes E. Agirre X. Chambwe N. Correa F. Jiang Y. Richards K.L. Betel D. Shaknovich R. Extracellular vesicles in DLBCL provide abundant clues to aberrant transcriptional programming and genomic alterations. Blood 2018 132 7 e13 e23 10.1182/blood‑2017‑12‑821843 29967128
    [Google Scholar]
  28. Bach D.H. Hong J.Y. Park H.J. Lee S.K. The role of exosomes and miRNAs in drug-resistance of cancer cells. Int. J. Cancer 2017 141 2 220 230 10.1002/ijc.30669 28240776
    [Google Scholar]
  29. Troppan K. Wenzl K. Deutsch A. Ling H. Neumeister P. Pichler M. MicroRNAs in diffuse large B-cell lymphoma: Implications for pathogenesis, diagnosis, prognosis and therapy. Anticancer Res. 2014 34 2 557 564 24510984
    [Google Scholar]
  30. Yuan W.X. Gui Y.X. Na W.N. Chao J. Yang X. Circulating microRNA-125b and microRNA-130a expression profiles predict chemoresistance to R-CHOP in diffuse large B-cell lymphoma patients. Oncol. Lett. 2016 11 1 423 432 10.3892/ol.2015.3866 26870228
    [Google Scholar]
  31. Kim S.W. Ramasamy K. Bouamar H. Lin A.P. Jiang D. Aguiar R.C.T. MicroRNAs miR-125a and miR-125b constitutively activate the NF-κB pathway by targeting the tumor necrosis factor alpha-induced protein 3 ( TNFAIP3, A20 ). Proc. Natl. Acad. Sci. USA 2012 109 20 7865 7870 10.1073/pnas.1200081109 22550173
    [Google Scholar]
  32. Due H. Svendsen P. Bødker J.S. Schmitz A. Bøgsted M. Johnsen H.E. El-Galaly T.C. Roug A.S. Dybkær K. miR-155 as a biomarker in B-Cell malignancies. BioMed Res. Int. 2016 2016 1 14 10.1155/2016/9513037 27294145
    [Google Scholar]
  33. Lopez-Santillan M. Larrabeiti-Etxebarria A. Arzuaga-Mendez J. Lopez-Lopez E. Garcia-Orad A. Circulating miRNAs as biomarkers in diffuse large B-cell lymphoma: A systematic review. Oncotarget 2018 9 32 22850 22861 10.18632/oncotarget.25230 29854319
    [Google Scholar]
  34. Alencar A.J. Malumbres R. Kozloski G.A. Advani R. Talreja N. Chinichian S. Briones J. Natkunam Y. Sehn L.H. Gascoyne R.D. Tibshirani R. Lossos I.S. MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP. Clin. Cancer Res. 2011 17 12 4125 4135 10.1158/1078‑0432.CCR‑11‑0224 21525173
    [Google Scholar]
  35. Filip A.A. Grenda A. Popek S. Koczkodaj D. Michalak-Wojnowska M. Budzyński M. Wąsik-Szczepanek E. Zmorzyński S. Karczmarczyk A. Giannopoulos K. Expression of circulating miRNAs associated with lymphocyte differentiation and activation in CLL—another piece in the puzzle. Ann. Hematol. 2017 96 1 33 50 10.1007/s00277‑016‑2840‑6 27730344
    [Google Scholar]
  36. Brown P.J. Ashe S.L. Leich E. Burek C. Barrans S. Fenton J.A. Jack A.S. Pulford K. Rosenwald A. Banham A.H. Potentially oncogenic B-cell activation–induced smaller isoforms of FOXP1 are highly expressed in the activated B cell–like subtype of DLBCL. Blood 2008 111 5 2816 2824 10.1182/blood‑2007‑09‑115113 18077790
    [Google Scholar]
  37. Banham A.H. Connors J.M. Brown P.J. Cordell J.L. Ott G. Sreenivasan G. Farinha P. Horsman D.E. Gascoyne R.D. Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma. Clin. Cancer Res. 2005 11 3 1065 1072 10.1158/1078‑0432.1065.11.3 15709173
    [Google Scholar]
  38. Gascoyne D.M. Banham A.H. The significance of FOXP1 in diffuse large B-cell lymphoma. Leuk. Lymphoma 2017 58 5 1037 1051 10.1080/10428194.2016.1228932 27678023
    [Google Scholar]
  39. Yu B. Zhou X. Li B. Xiao X. Yan S. Shi D. FOXP1 expression and its clinicopathologic significance in nodal and extranodal diffuse large B-cell lymphoma. Ann. Hematol. 2011 90 6 701 708 10.1007/s00277‑010‑1124‑9 21120478
    [Google Scholar]
  40. Cao D. Jiang Y. Feng Y. Jing C.X. Xu J. Xu C.G. The value of circulating exsomal miR-451a to monitor therapy response in diffuse large B cell lymphoma. Sichuan Da Xue Xue Bao Yi Xue Ban 2018 49 3 399 403 30014642
    [Google Scholar]
  41. Chen Z. You L. Wang L. Huang X. Liu H. Wei J. Zhu L. Qian W. Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo. J. Exp. Clin. Cancer Res. 2018 37 1 190 10.1186/s13046‑018‑0863‑7 30103789
    [Google Scholar]
  42. Koch R. Demant M. Aung T. Diering N. Cicholas A. Chapuy B. Wenzel D. Lahmann M. Güntsch A. Kiecke C. Becker S. Hupfeld T. Venkataramani V. Ziepert M. Opitz L. Klapper W. Trümper L. Wulf G.G. Populational equilibrium through exosome-mediated Wnt signaling in tumor progression of diffuse large B-cell lymphoma. Blood 2014 123 14 2189 2198 10.1182/blood‑2013‑08‑523886 24563408
    [Google Scholar]
  43. Koch R. Aung T. Vogel D. Chapuy B. Wenzel D. Becker S. Sinzig U. Venkataramani V. von Mach T. Jacob R. Truemper L. Wulf G.G. Nuclear trapping through inhibition of exosomal export by indomethacin increases cytostatic efficacy of doxorubicin and pixantrone. Clin. Cancer Res. 2016 22 2 395 404 10.1158/1078‑0432.CCR‑15‑0577 26369630
    [Google Scholar]
  44. Aung T. Chapuy B. Vogel D. Wenzel D. Oppermann M. Lahmann M. Weinhage T. Menck K. Hupfeld T. Koch R. Trümper L. Wulf G.G. Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3. Proc. Natl. Acad. Sci. USA 2011 108 37 15336 15341 10.1073/pnas.1102855108 21873242
    [Google Scholar]
/content/journals/chr/10.2174/011570162X288575240821201433
Loading
MicroRNA Expression in Exosome Extracellular Vesicles as Targets for Personalized Medicine in Diffuse Large B Cell Lymphoma Patients with HIV Infection
Bentham Science Publishers ; https://doi.org/10.2174/011570162X288575240821201433
/content/journals/chr/10.2174/011570162X288575240821201433
/content/journals/chr/10.2174/011570162X288575240821201433
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: HIV ; EVs ; microRNA ; DLBCL ; Biomarkers ; exosomes
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test